These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28434662)

  • 21. Drug eluting balloons for resistant arteriovenous dialysis access stenosis.
    Karnabatidis D; Kitrou P
    J Vasc Access; 2017 Mar; 18(Suppl. 1):88-91. PubMed ID: 28297068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis.
    Trerotola SO; Saad TF; Roy-Chaudhury P;
    J Vasc Interv Radiol; 2020 Jan; 31(1):1-14.e5. PubMed ID: 31706886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty.
    Aftab SA; Tay KH; Irani FG; Gong Lo RH; Gogna A; Haaland B; Tan SG; Chng SP; Pasupathy S; Choong HL; Tan BS
    J Vasc Interv Radiol; 2014 Feb; 25(2):190-8. PubMed ID: 24315548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plain versus paclitaxel-coated balloon angioplasty in arteriovenous fistula and graft stenosis: An umbrella review.
    Lazarides MK; Christaina E; Antoniou GA; Argyriou C; Trypsianis G; Georgiadis GS
    J Vasc Access; 2022 Nov; 23(6):981-988. PubMed ID: 34058909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Marticorena Garcia SR; Langmann M; Schnorr B; Günther RW; Hamm B; Althoff CE
    Rofo; 2016 Apr; 188(4):374-80. PubMed ID: 27002498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study.
    Swinnen JJ; Zahid A; Burgess DC
    J Vasc Access; 2015; 16(5):388-93. PubMed ID: 26044898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up.
    Phang CC; Tan RY; Pang SC; Tan CW; Teh SP; Cheng RW; Kho YX; Chong TT; Gogna A; Foo WY; Tan CS
    Nephrology (Carlton); 2019 Dec; 24(12):1290-1295. PubMed ID: 30901497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of functional patency rates between paclitaxel-eluting versus plain balloon angioplasty in hemodialysis patients with central venous stenosis: An intra-individual comparison study.
    Cakir S; Guzelbey T; Mutlu IN; Kilickesmez O
    Ther Apher Dial; 2022 Feb; 26(1):185-190. PubMed ID: 33891365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472).
    Kitrou PM; Katsanos K; Spiliopoulos S; Karnabatidis D; Siablis D
    Eur J Radiol; 2015 Mar; 84(3):418-423. PubMed ID: 25575743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts.
    Ierardi AM; Franchin M; Fontana F; Piffaretti G; Duka E; Tonolini M; Miele V; Tozzi M; Carrafiello G
    Radiol Med; 2017 Jan; 122(1):69-76. PubMed ID: 27601144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel coated-balloon (PCB) versus standard plain old balloon (POB) fistuloplasty for failing dialysis access.
    Karmota AG
    Ann R Coll Surg Engl; 2020 Oct; 102(8):601-605. PubMed ID: 32538115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel-Coated Balloons Compared to Plain Balloon Angioplasty in the Management of Dysfunctional Arteriovenous Fistulae: A Single-Center Randomized Clinical Trial.
    Arabi M; Salman R; Alharbi A; Alzahrani Y; Bashir O; Qazi S; Abdallah M; Farooqui M; Hejaili F; Almoaiqel M
    Saudi J Kidney Dis Transpl; 2021; 32(1):118-127. PubMed ID: 34145121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel-coated balloon plus bare-metal stent for de-novo coronary artery disease: final 5-year results of a randomized prospective multicenter trial.
    Seeger J; Markovic S; Birkemeyer R; Rittger H; Jung W; Brachmann J; Rottbauer W; Wöhrle J
    Coron Artery Dis; 2016 Mar; 27(2):84-8. PubMed ID: 26479969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
    Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
    J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study.
    Karnabatidis D; Kitrou P; Spiliopoulos S; Katsanos K; Diamantopoulos A; Christeas N; Siablis D
    J Nephrol; 2013; 26(2):389-95. PubMed ID: 22641574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Drug-Coated Balloons in Dysfunctional Arteriovenous Dialysis Access Treatment: The Effect of Consecutive Treatments on Lesion Patency.
    Kitrou PM; Katsanos K; Spyridonidis I; Theofanis M; Papachristou E; Papadoulas S; Karnabatidis D
    J Vasc Interv Radiol; 2019 Feb; 30(2):212-216. PubMed ID: 30717952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease.
    Wöhrle J; Birkemeyer R; Markovic S; Nguyen TV; Sinha A; Miljak T; Spiess J; Rottbauer W; Rittger H
    Heart; 2011 Aug; 97(16):1338-42. PubMed ID: 21617163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy of Paclitaxel Drug-Eluting Balloon Angioplasty Versus Standard Balloon Angioplasty in Stenosis of Native Hemodialysis Arteriovenous Fistulas: An Analysis of Clinical Success, Primary Patency and Risk Factors for Recurrent Dysfunction.
    Yildiz I
    Cardiovasc Intervent Radiol; 2019 May; 42(5):685-692. PubMed ID: 30719539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Hemodialysis Vascular Access Repeated Stenosis with Paclitaxel-Coated Balloon Angioplasty: A Retrospective Study.
    Chen C; Gao J; Gong F; Liu L; Shi P; Ma S
    Blood Purif; 2024; 53(6):486-492. PubMed ID: 38198755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.